Phase I Biomarker Study of Dietary Grape-Derived Low Dose Resveratrol for Colon Cancer Prevention

Clinical Trial ID NCT00578396

PubWeight™ 10.78^‹?›

🔗 Visit the ClinicalTrials.gov page for NCT00578396

Top papers